Yuji Takahashi

Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer.

M. Monden, K. Dono, H. Nagano, 2007, Anticancer research.

Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts.

Y. Takeda, M. Monden, K. Dono, 2008, Anticancer research.

Androgen Receptor Silences Thioredoxin‐interacting Protein and Competitively Inhibits Glucocorticoid Receptor‐Mediated Apoptosis in Pancreatic β‐Cells

H. Inui, Y. Nakano, T. Adachi, 2015, Journal of cellular biochemistry.

Schedule-dependent Therapeutic Effects of Gemcitabine Combined with Uracil-Tegafur in a Human Pancreatic Cancer Xenograft Model

M. Monden, K. Dono, H. Nagano, 2006, Pancreas.

Androgen signaling expands β-cell mass in male rats and β-cell androgen receptor is degraded under high-glucose conditions.

H. Inui, Naoki Harada, R. Yamaji, 2018, American journal of physiology. Endocrinology and metabolism.

Expression of Uridine Diphosphate N-Acetyl-α-D-Galactosamine: Polypeptide N-Acetylgalactosaminyl Transferase 3 in Adenocarcinoma of the Pancreas

Hiroaki Nagano, Morito Monden, Shinji Yamamoto, 2003, Pathobiology.

Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer

Y. Takeda, M. Monden, K. Dono, 2007, International journal of cancer.